| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 16.95B | 17.12B | 20.01B | 18.40B | 14.10B |
| Gross Profit | 3.74B | 4.00B | 4.60B | 4.90B | 4.12B |
| EBITDA | 564.80M | 1.36B | 809.76M | 980.25M | 1.08B |
| Net Income | 512.92M | 712.67M | 759.44M | 1.14B | 954.93M |
Balance Sheet | |||||
| Total Assets | 18.43B | 17.07B | 16.96B | 16.90B | 13.09B |
| Cash, Cash Equivalents and Short-Term Investments | 3.92B | 4.44B | 5.14B | 5.79B | 3.96B |
| Total Debt | 4.58B | 3.17B | 2.21B | 2.39B | 2.09B |
| Total Liabilities | 6.99B | 5.30B | 4.83B | 5.28B | 4.31B |
| Stockholders Equity | 11.42B | 11.74B | 12.11B | 11.60B | 8.75B |
Cash Flow | |||||
| Free Cash Flow | -139.46M | 318.06M | 568.08M | 674.99M | 976.82M |
| Operating Cash Flow | 603.09M | 719.94M | 764.78M | 962.14M | 1.15B |
| Investing Cash Flow | -1.28B | -1.44B | -649.68M | -529.52M | -191.69M |
| Financing Cash Flow | 50.49M | -514.03M | -780.74M | 1.38B | 361.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | HK$393.14M | 13.34 | 5.83% | 6.67% | -1.26% | -10.80% | |
| ― | HK$272.05M | 10.58 | 4.67% | 3.39% | 5.87% | 54.21% | |
| ― | HK$828.85M | 39.02 | 1.79% | 2.65% | 9.05% | ― | |
| ― | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
| ― | $15.44B | 24.38 | 4.70% | 0.89% | 5.43% | -6.88% | |
| ― | HK$438.00M | 48.50 | 4.04% | 7.14% | 20.83% | -75.45% | |
| ― | $4.30B | ― | -4.20% | 2.44% | -6.07% | 86.55% |
Chinasoft International Limited announced that its major shareholder, Chairman, and Executive Director, Dr. Chen Yuhong, has increased his shareholding in the company by acquiring 1,000,000 ordinary shares on the open market. This move, representing approximately 0.04% of the total issued shares, is seen as a demonstration of Dr. Chen’s confidence in the company’s future growth potential and business development.
The most recent analyst rating on (HK:0354) stock is a Buy with a HK$7.50 price target. To see the full list of analyst forecasts on Chinasoft International stock, see the HK:0354 Stock Forecast page.
Chinasoft International Limited announced a voluntary update regarding a significant shareholding increase by its major shareholder, Chairman, and Executive Director, Dr. Chen Yuhong. On 23 September 2025, Dr. Chen acquired an additional 1,500,000 shares, following a previous acquisition in July, reflecting his confidence in the company’s future growth and business development. This acquisition increases Dr. Chen’s holdings to approximately 11.68% of the total issued shares, signaling strong internal belief in the company’s value and potential.
The most recent analyst rating on (HK:0354) stock is a Buy with a HK$7.50 price target. To see the full list of analyst forecasts on Chinasoft International stock, see the HK:0354 Stock Forecast page.
Chinasoft International Limited announced a change in the use of proceeds from its 2021 placing agreement, which initially raised approximately HK$1,970 million. The company has extended the timeline for utilizing the remaining HK$394 million of unutilized net proceeds for the development of HarmonyOS and OpenHarmony products and solutions, now expected to be used by the end of 2025. This strategic adjustment reflects Chinasoft’s ongoing commitment to enhancing its technological offerings and expanding its market presence in the HarmonyOS and OpenHarmony ecosystem.
The most recent analyst rating on (HK:0354) stock is a Buy with a HK$7.50 price target. To see the full list of analyst forecasts on Chinasoft International stock, see the HK:0354 Stock Forecast page.
Chinasoft International Limited has been shortlisted for Sinochem Info’s 2025-2027 Centralized Procurement Project, which involves consulting, ERP, and implementation & operation and maintenance services. This achievement highlights Chinasoft’s capabilities in digital transformation and strengthens its strategic position in the energy sector, particularly among central state-owned enterprises, as it aims to contribute to the industry’s high-quality development.
The most recent analyst rating on (HK:0354) stock is a Hold with a HK$6.30 price target. To see the full list of analyst forecasts on Chinasoft International stock, see the HK:0354 Stock Forecast page.
Chinasoft International Limited has been elected as the city partner for the OpenHarmony Innovative Applications and HarmonyOS Ecosystem Construction in Xi’an’s smart transportation sector. This recognition from the Xi’an Municipal Government highlights Chinasoft’s technological prowess and ecosystem-building capabilities. The company will collaborate with partners to implement a comprehensive smart transportation system, focusing on data management, platform integration, and system equipment transformation. This initiative is expected to accelerate the large-scale implementation of OpenHarmony technology and contribute to Xi’an’s development as a national smart transportation innovation pilot.
The most recent analyst rating on (HK:0354) stock is a Hold with a HK$6.00 price target. To see the full list of analyst forecasts on Chinasoft International stock, see the HK:0354 Stock Forecast page.
Chinasoft International Limited reported a positive financial performance for the first half of 2025, with a 7.3% increase in revenue and a 10.4% rise in profit compared to the same period in 2024. The company’s strategic focus on service revenue contributed to a 7.8% growth in this segment, and the basic earnings per share increased by 15.6%. Despite these gains, the directors decided not to recommend an interim dividend, reflecting a cautious approach to financial management.
The most recent analyst rating on (HK:0354) stock is a Hold with a HK$6.00 price target. To see the full list of analyst forecasts on Chinasoft International stock, see the HK:0354 Stock Forecast page.
Chinasoft International Limited has announced a board meeting scheduled for August 25, 2025, to discuss several key matters, including the approval of the company’s unaudited results for the first half of 2025 and the consideration of an interim dividend. This meeting could impact the company’s financial strategy and stakeholder interests, as it will address important financial disclosures and potential shareholder returns.
The most recent analyst rating on (HK:0354) stock is a Hold with a HK$5.60 price target. To see the full list of analyst forecasts on Chinasoft International stock, see the HK:0354 Stock Forecast page.